Your browser doesn't support javascript.
loading
Potentially Life-Threatening Interaction between Opioids and Intrathecal Baclofen in Individuals with a Childhood-Onset Neurological Disorder: A Case Series and Review of the Literature.
van Dijk, Liza M M; van Zwol, Annelies; Buizer, Annemieke I; van de Pol, Laura A; Slot, K Mariam; de Wildt, Saskia N; Bonouvrié, Laura A.
Afiliación
  • van Dijk LMM; Department of Rehabilitation Medicine, Amsterdam University Medical Centers, Location Vrije Universiteit, Amsterdam, the Netherlands.
  • van Zwol A; Amsterdam Movement Sciences, Rehabilitation & Development, Amsterdam, The Netherlands.
  • Buizer AI; Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van de Pol LA; Department of Rehabilitation Medicine, Amsterdam University Medical Centers, Location Vrije Universiteit, Amsterdam, the Netherlands.
  • Slot KM; Amsterdam Movement Sciences, Rehabilitation & Development, Amsterdam, The Netherlands.
  • de Wildt SN; Emma Children's Hospital, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Bonouvrié LA; Department of Child Neurology, Amsterdam University Medical Centers, Location Vrije Universiteit, Amsterdam, The Netherlands.
Neuropediatrics ; 2024 May 22.
Article en En | MEDLINE | ID: mdl-38776978
ABSTRACT

BACKGROUND:

Spasticity and dystonia are movement impairments that can occur in childhood-onset neurological disorders. Severely affected individuals can be treated with intrathecal baclofen (ITB). Concomitant use of ITB and opioids has been associated with central nervous system (CNS) depression. This study aims to describe the clinical management of this interaction, based on a case series and review of literature.

METHODS:

Four individuals with childhood-onset CNS disorders (age 8-24) and CNS-depressant overdose symptoms after the concomitant use of ITB and opioids are described. The Drug Interaction Probability Scale (DIPS) was calculated to assess the cause-relationship (doubtful <2, possible 2-4, probable 5-8, and highly probable >8) of the potential drug-drug interaction. A literature review of similar previously reported cases and the possible pharmacological mechanisms of opioid-baclofen interaction is provided.

RESULTS:

After ITB and opioid co-administration, three out of four patients had decreased consciousness, and three developed respiratory depression. DIPS scores indicated a possible cause-relationship in one patient (DIPS 4) and a probable cause-relationship in the others (DIPS 6, 6, and 8). Discontinuation or adjusting ITB or opioid dosages resulted in clinical recovery. All patients recovered completely. In the literature, two articles describing nine unique cases were found.

CONCLUSION:

Although the opioid-ITB interaction is incompletely understood, concomitant use may enhance the risk of symptoms of CNS-depressant overdose, which are potentially life-threatening. If concomitant use is desirable, we strongly recommend to closely monitor these patients to detect interaction symptoms early. Awareness and monitoring of the potential opioid-ITB interaction is essential to reduce the risk of severe complications.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neuropediatrics Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neuropediatrics Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos
...